A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis
Clinical trial NCT06906900 · RECRUITING
Trial details
- NCT number
- NCT06906900
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2027-02-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.